Back to Results
First PageMeta Content
Johnson & Johnson / Business


Press Release Ganymed names James A. Ratigan CEO Mainz, November 11, 2003 Ganymed Pharmaceuticals AG, an independent biotechnology company that identifies and validates antigen targets to improve therapeutics for life th
Add to Reading List

Document Date: 2015-02-04 05:15:01


Open Document

File Size: 13,47 KB

Share Result on Facebook